MoviPrep is indicated for cleansing of the colon as a preparation for colonoscopy in adults 18 years of age and older. It is a tolerable, low–volume
2–liter PEG with the effectiveness of a high–volume prep. MoviPrep is proven to provide consistent visibility throughout the entire colon.
MoviPrep has a proven PM/AM Split Dosing regimen, which improves quality bowel preparation and colonoscopy. In a clinical trial evaluating PM/AM
Split Dosing vs evening–only dosing, the total number of flat lesions detected in patients who received some preparation the same day as the
colonoscopy was significantly higher than in those prepared the evening before.3 In another study, 89.3% of bowel preparations were
effective when split dosed vs 69.5% for evening–only preparations.4
MOVIPREP® (PEG-3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate and ascorbic acid for oral solution) is indicated for cleansing of the
colon as a preparation for colonoscopy in adults 18 years of age or older. MOVIPREP is contraindicated in patients who have had a severe hypersensitivity reaction
to any of its components. MOVIPREP should be used with caution in patients using concomitant medications that increase the risk of electrolyte abnormalities, in patients with known or suspected hyponatremia,
severe ulcerative colitis, ileus, gastrointestinal obstruction or perforation, gastric retention, toxic colitis, toxic megacolon, or glucose-6-phosphate dehydrogenase deficiency. In clinical trials, abdominal
distention, anal discomfort, thirst, nausea, and abdominal pain were the most common adverse reactions to MOVIPREP administration. MOVIPREP contains a maximum of 2.33 mg of phenylalanine per treatment.
Consult with your physician to see if this product is right for you.
For complete Prescribing Information, please click here.
For product information, adverse event reports, and product complaint reports please call:
Salix Product Information Call Center
Phone: 1-800-508-0024
Fax: 1-510-595-8183
Email: